Long-term efficacy and tolerability of add-on pioglitazone therapy to failing monotherapy compared with addition of gliclazide or metformin in patients with type 2 diabetes.

Long-term efficacy and tolerability of add-on pioglitazone therapy to failing monotherapy compared with addition of gliclazide or metformin in patients with type 2 diabetes.

AIMS/HYPOTHESIS: The aim of this analysis was to examine the long-term effects of pioglitazone or gliclazide addition to failing metformin monotherapy and pioglitazone or metformin addition to failing sulphonylurea monotherapy in patients with type 2 diabetes. METHODS: Two 2-year, randomised, multic...

Full description

Bibliographic Details
Main Authors:	Charbonnel, B, Schernthaner, G, Brunetti, P, Matthews, DR, Urquhart, R, Tan, M, Hanefeld, M
Format:	Journal article
Language:	English
Published:	2005

Similar Items

Long-term therapy with addition of pioglitazone to metformin compared with the addition of gliclazide to metformin in patients with type 2 diabetes: a randomized, comparative study.
by: Matthews, DR, et al.
Published: (2005)

A long-term comparison of pioglitazone and gliclazide in patients with Type 2 diabetes mellitus: a randomized, double-blind, parallel-group comparison trial.
by: Charbonnel, B, et al.
Published: (2005)

Safety and tolerability of pioglitazone, metformin, and gliclazide in the treatment of type 2 diabetes.
by: Belcher, G, et al.
Published: (2005)

Efficacy and safety of pioglitazone versus metformin in patients with type 2 diabetes mellitus: a double-blind, randomized trial.
by: Schernthaner, G, et al.
Published: (2004)

One-year glycemic control with a sulfonylurea plus pioglitazone versus a sulfonylurea plus metformin in patients with type 2 diabetes.
by: Hanefeld, M, et al.
Published: (2004)

Pioglitazone and metformin.
by: Hill, N, et al.
Published: (2007)

Inhibition of P-glycoprotein expression and function by anti-diabetic drugs gliclazide, metformin, and pioglitazone in vitro and in situ
by: Mehran Mesgari Abbasi, et al.
Published: (2016-01-01)

Pioglitazone/metformin - Viewpoint
by: Matthews, DR
Published: (2006)

Effects of gliclazide add on metformin on serum omentin-1 levels in patients with type 2 diabetes mellitus
by: Ali I Al-Gareeb, et al.
Published: (2016-01-01)

Safety and tolerability of pioglitazone
by: Belcher, G, et al.
Published: (2000)

Pioglitazone/Metformin: A viewpoint by David R. Matthews
by: Matthews, DR
Published: (2006)

Liraglutide add-on to metformin improves postprandial glucose control compared with metformin monotherapy in patients with Type 2 diabetes: posthoc analysis of the Liraglutide Effect and Action in Diabetes (LEAD)2 study
by: Stephens, J, et al.
Published: (2014)

Comparison of efficacy of add-on therapy of teneligliptin versus pioglitazone among type 2 diabetes mellitus patients ineptly controlled on dual therapy of metformin plus sulfonylurea
by: Vanjari Nikhil Kumar, et al.
Published: (2019-01-01)

Comparison of efficacy of add-on therapy of vildagliptin versus pioglitazone among Type 2 Diabetes Mellitus patients inadequately controlled on dual therapy of metformin plus sulfonylurea
by: Kirandeep Kaur
Published: (2014-02-01)

Attenuation of lipid peroxidation and atherogenic factors in diabetic patients treated with gliclazide and metformin
by: Sujan Banik, et al.
Published: (2018-01-01)

Metformin and pioglitazone are effective in reducing the levels of leptin and omentin
Published: (2013-03-01)

A meta-analysis of randomized clinical trials on the effect of metformin vs. pioglitazone monotherapy on plasma adiponectin levels among patients with diabetes mellitus
by: Roselle Arbas, et al.
Published: (2024-01-01)

Comparison of Pioglitazone and Metformin Efficacy against Glucocorticoid Induced Atherosclerosis and Hepatic Steatosis in Insulin Resistant Rats
by: I M Nagendra Nayak, et al.
Published: (2017-07-01)

Cardiovascular Safety of Sodium Glucose Cotransporter 2 Inhibitors as Add-on to Metformin Monotherapy in Patients with Type 2 Diabetes Mellitus
by: Ja Young Jeon, et al.
Published: (2021-07-01)

Valsartan in combination with metformin and gliclazide in diabetic rat model using developed RP-HPLC method
by: Rasmita Patra, et al.
Published: (2021-08-01)

Correction: A meta-analysis of randomized clinical trials on the effect of metformin vs. pioglitazone monotherapy on plasma adiponectin levels among patients with diabetes mellitus
by: Roselle Arbas, et al.
Published: (2024-03-01)

Effect of Gliclazide or Gliclazide plus Metformin Combination on Glycemic Control in Patients with T2DM in India: A Real-World, Retrospective, Longitudinal, Observational Study from Electronic Medical Records
by: Nareen Krishna Polavarapu, et al.
Published: (2020-07-01)

Predictors of HbA1c treatment response to add-on medication following metformin monotherapy: a population-based cohort study
by: Wei Ying Tan, et al.
Published: (2023-11-01)

Combination of Pioglitazone and Metformin Actions on Liver Lipid Metabolism in Obese Mice
by: Jieying Liu, et al.
Published: (2023-07-01)

Alogliptin in combination with metformin and pioglitazone for the treatment of type 2 diabetes mellitus
by: Holl, et al.
Published: (2014-07-01)

Comparison clinical and metabolic effects of metformin and pioglitazone in polycystic ovary syndrome
by: Karoon Shahebrahimi, et al.
Published: (2016-01-01)

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.
by: Kahn, SE, et al.
Published: (2006)

The physiological action of gliclazide: beta-cell function and insulin resistance.
by: Matthews, DR, et al.
Published: (1991)

Time to Treatment Intensification in Patients Receiving DPP4 Inhibitors Versus Sulfonylureas as the First Add-On to Metformin Monotherapy: A Retrospective Cohort Study
by: Giuseppe Roberto, et al.
Published: (2022-05-01)

Low risk of hypoglycemia and high efficacy of gliclazide MB: results of recent studies
by: I. V. Kononenko, et al.
Published: (2021-11-01)

Imaging Metformin Efficacy as Add-On Therapy in Cells and Mouse Models of Human EGFR Glioblastoma
by: Silvia Valtorta, et al.
Published: (2021-05-01)

Effect of combined gliclazide/metformin treatment on oxidative stress, lipid profile, and hepatorenal functions in type 2 diabetic patients
by: Mansour Alsharidah, et al.
Published: (2018-01-01)

Effect of a New Formulation of Nutraceuticals as an Add-On to Metformin Monotherapy for Patients with Type 2 Diabetes and Suboptimal Glycemic Control: A Randomized Controlled Trial
by: Giovanni Sartore, et al.
Published: (2021-07-01)

The Efficacy and Safety of Chinese Herbal Medicine Jinlida as Add-On Medication in Type 2 Diabetes Patients Ineffectively Managed by Metformin Monotherapy: A Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial.
by: Fengmei Lian, et al.
Published: (2015-01-01)

Effect of Pioglitazone as Additional Therapy on Glycaemic Control
by: Habibullah Khan, et al.
Published: (2004-06-01)

Patient-reported outcomes in patients with type 2 diabetes treated with liraglutide or glimepiride, both as add-on to metformin.
by: Hermansen, K, et al.
Published: (2010)

Deduction of the operable design space of RP-HPLC technique for the simultaneous estimation of metformin, pioglitazone, and glimepiride
by: Aya A. Marie, et al.
Published: (2023-03-01)

Double-blind, randomized, multicentre, and active comparator controlled investigation of the effect of Pioglitazone, Metformin, and the combination of both on cardiovascular risk in patients with type 2 diabetes receiving stable basal insulin therapy: the PIOCOMB study
by: Kleine Iris, et al.
Published: (2011-07-01)

Fabrication and Characterization of Gliclazide Loaded Microcapsules
by: Muhammad Asad, et al.
Published: (2014-12-01)

A Histomorphological Comparative Effects of Metformin, Pioglitazone, Repaglinide and Acarbose on Polycystic Ovary in Mice
by: fariba noori, et al.
Published: (2020-04-01)